Alzheimer’s disease, frontotemporal dementias, progressive supranuclear palsy, Corticobasal degeneration,   Clinical Trial Study

A First in Human Phase 1 Study in Healthy Volunteers and Heterozygous Carriers of a Loss-of-function Granulin Mutation Causative of Frontotemporal Dementia to Assess AL001 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics (AL001-1)

ID
NCT03636204
Condition Studied
Frontotemporal Dementia
Phase
Phase I
Status
Closed
Intervention
AL001

Please go to ClinicalTrials.gov for more information.